Editorial: EU must rethink vaccine strategy after its misstep
By underestimating the logistics of a mass vaccination rollout, European leaders risk failing their citizens on this vital issue
AstraZeneca has made few friends in the weeks since it unveiled a Covid-19 vaccine along with Oxford University. Since that joint achievement, the vaccine has been clouded by doubts, and an impression that the Anglo-Swedish pharmaceutical company’s focus is as much on the stock market as on the pandemic.
During testing of the vaccine, AstraZeneca got into a row with the US Food and Drug Administration over the conduct of a clinical trial....
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month, €19.99 Monthly thereafter
*New subscribers only
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team
Editorial: We all need to be ambitious in our fight against climate change
An unprecedented level of change right across our economy and society is needed to beat the climate crisis
Editorial: North’s leaders have a duty to address the causes of disturbing street violence
Success of vaccination programme in the North shows what can be achieved collectively if the will is there
Editorial: Standing still on infrastructure is simply not an option
The upcoming review of the National Development Plan is a chance for us to take stock of the country’s creaking infrastructure
Editorial: Biden’s plan puts Irish corporate tax regime back into focus again
The most objectionable aspect of Ireland’s corporate tax regime in the eyes of its critics is not the 12.5 per cent rate, but the jungle of loopholes and special arrangements that flourish beneath and around it.